277 (Januvia 100 mg)
Generic Name: sitagliptin
Pill imprint 277 has been identified as Januvia 100 mg.
Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 277
- Generic Name:
- 100 mg
- 10.00 mm
- Prescription only
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Merck & Company Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
ferric oxide red
sodium stearyl fumarate
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|54569-5925||A S Medication Solutions LLC (repackager)|
|54868-5840||Physicians Total Care Inc (repackager)|
|35356-0103||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about Januvia (sitagliptin)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.